These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18308996)

  • 1. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
    Macrae JM; Dojcinovic I; Djurdjev O; Jung B; Shalansky S; Levin A; Kiaii M
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):369-74. PubMed ID: 18308996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of citrate 4% and heparin as tunneled-catheters-locking solution in chronic hemodialysis].
    Chazot G; Mehdi M; Lorriaux C; Deleaval P; Mayor B; Jean G; Chazot C; Lechevallier S; Moncel O; Vo-Van C; Hurot JM
    Nephrol Ther; 2018 Feb; 14(1):42-46. PubMed ID: 29191576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
.
    Abdel Azim ABE; ElSaid TW; El Said HW; Hemida W; Zaghlool S; Ramadan A; Gouda Z; El Masry S; Reda W; Ali HM
    Clin Nephrol; 2018 Nov; 90(5):341-349. PubMed ID: 30148449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
    Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
    Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
    J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
    Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
    J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.
    Dogra GK; Herson H; Hutchison B; Irish AB; Heath CH; Golledge C; Luxton G; Moody H
    J Am Soc Nephrol; 2002 Aug; 13(8):2133-9. PubMed ID: 12138146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
    Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Bhargava R; Mitsides N; Heap M; Green G; Diggle P
    Semin Dial; 2012; 25(2):233-8. PubMed ID: 21916999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
    Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
    Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.